DRMA
Dermata Therapeutics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
Latest data update time: Updated on 2026-02-07
3.82 / 10Overall Score
NeturalInvestment Rating
3.82 / 10Overall Score
NeturalInvestment Rating
Trend Analysis of DRMA
- Based on a composite score of 3.82/10, we rate DRMA as a Netural. Our analysis breaks down into 3.41/10 for Fundamentals, 1.44/10 for Technicals, and 5.21/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Technical Analysis of DRMA?
Is DRMA undervalued or overvalued?
Is money flowing into or out of DRMA?
Trend Analysis of DRMA
- Based on a composite score of 3.82/10, we rate DRMA as a Netural. Our analysis breaks down into 3.41/10 for Fundamentals, 1.44/10 for Technicals, and 5.21/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is DRMA undervalued or overvalued?
Technical Analysis of DRMA?
Is money flowing into or out of DRMA?
